Laura Antonucci

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Multidrug Resistant

Oxidative Stress

Papillary Thyroid

Top Venues

Cancer prevention research (Philadelphia, Pa.)

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) 17 (4) (2024)
Laura Antonucci, Michael Karin
The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.) (2024)
Yixuan Zhou, Ingmar Niels Bastian, Mark D Long, Michelle Dow, Weihua Li, Tao Liu, Rachael Katie Ngu, Laura Antonucci, Jian Yu Huang, Qui T Phung, Xi-He Zhao, Sourav Banerjee, Xue-Jia Lin, Hongxia Wang, Brian Dang, Sylvia Choi, Daniel Karin, Hua Su, Mark H Ellisman, Christina Jamieson, Marcus Bosenberg, Zhang Cheng, Johannes Haybaeck, Lukas Kenner, Kathleen M Fisch, Richard Bourgon, Genevive Hernandez, Jennie R Lill, Song Liu, Hannah Carter, Ira Mellman, Michael Karin, Shabnam Shalapour
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)